Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital

Alcohol Intake in Patients With Cardiomyopathy and Heart Failure: Consensus and Controversy

Research output: Contribution to journalReviewResearchpeer-review

  1. Recurrent syncope in patients with a pacemaker and bradyarrhythmia

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Polygenic risk score for ACE-inhibitor-associated cough based on the discovery of new genetic loci

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Diagnostic and prognostic value of the electrocardiogram in stable outpatients with type 2 diabetes

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Symptoms reported in calls to emergency medical services within 24 hours prior to out-of-hospital cardiac arrest

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Alcohol is often cited to be a common cause of cardiomyopathy and heart failure. However, in most available population-based studies, a modest-to-moderate alcohol consumption has been associated with favorable effects on the cardiovascular system, including a lowered risk of heart failure, compared with no alcohol consumption. Available genetic epidemiological data have not supported a causal association between alcohol consumption and heart failure risk, suggesting that alcohol may not be a common cause of heart failure in the community. Data linking alcohol intake with cardiomyopathy risk are sparse, and the concept of alcoholic cardiomyopathy stems mainly from case series of selected patients with dilated cardiomyopathy, where a large proportion reported a history of excessive alcohol intake. This state-of-the-art paper addresses the current knowledge of the epidemiology of alcoholic cardiomyopathy and the role of alcohol intake in patients with non-alcohol-related heart failure. It also offers directions to future research in the area. The review questions the validity of current clinical teaching in the area. It is not well known how much alcohol is needed to cause disease, and the epidemiological pathways linking alcohol consumption to cardiomyopathy and heart failure are not well understood. Until more evidence becomes available, caution is warranted before labeling patients as having alcoholic cardiomyopathy due to a risk of neglecting other contributors, such as genetic causes of cardiomyopathy. In non-alcohol-related heart failure, it is unknown whether total abstinence is improving outcomes (compared with moderate drinking). Ideally, randomized clinical trials are needed to answer this question.

Original languageEnglish
JournalCirculation. Heart failure
Issue number8
Pages (from-to)e009459
Publication statusPublished - Aug 2022

ID: 78192469